GUGLIELMONE HUGO ALBERTO
Congresos y reuniones científicas
The antithrombotic in vivo effects of quercetin-tetra-sulphate (QTS) isolated from Flaveria bidentis in an experimental thrombosis model in mice
XXVI Congress of the International Society on Thrombosis and Haemostasis
Lugar: Berlin; Año: 2017;
Treatment of a rare case of congenital a/hypo dysfibrinogenemia with fibrinogen concentrates: comparison between fibrinogen levels and ROTEM® parameters
XXV Congress of the International Society on Thrombosis and Haemostasis
Lugar: Berlin; Año: 2017;
Are useful the screening coagulation tests to predict the clinical phenotype in patients with a / dysfibrinogenemia? A single institution experience.
XXVI Congress of the International Society on Thrombosis and Haemostasis
Lugar: Berlin; Año: 2017;
Sequencing of FGA, FGB and FGG reveals both novel and previously described mutations in patients with congenital fibrinogen deficiencies.
XXV Congress of the International Society on Thrombosis and Haemostasis
Lugar: Toronto; Año: 2015;
Two families from Argentina with factor X deficiency due two different mutations (p.Cys241Gly and p.Gln138Arg)
XXV Congress of the International Society on Thrombosis and Haemostasis
Lugar: Toronto; Año: 2015;
Percentage of platelet aggregates and macroplatelets: a potential useful laboratory parameters for predicting bleeding in von Willebrand disease type 2B (VWD2B) with the p.Val1316Met mutation.
XXV Congress of the International Society on Thrombosis and Haemostasis
Lugar: Toronto; Año: 2015;
Poor response to 1-desamino-8-D arginine vasopressin (DDAVP) test in a patient with von Willebrand disease type 2M (VWD2M) with p.Glu1549Lys mutation.
XXV Congress of the International Society on Thrombosis and Haemostasis
Lugar: Toronto; Año: 2015;
Mutación V1316M en enfermedad de von Willebrand 2B con macrotrombocitopenia (Síndrome de Plaquetas Montreal): Un estudio familiar.
XI Congreso Argentino de Hemostasia y Trombosis
Lugar: Buenos Aires; Año: 2014;
GUGLIELMONE HUGO A
Molecular characterization of the fibrinogen in seven patients unrelated from Cordoba, Argentina
XIV International Congress of the International Society on Thrombosis and Haemostasis
Año: 2013;
GUGLIELMONE HUGO A
Purification and characterization of a new fibrinogen concentrate: results at laboratory scale
XIV International Congress of the International Society on Thrombosis and Haemostasis
Año: 2013;
Studies on the thrombogenicity of immunoglobulins manufactured in UNC-Hemoderivados: a comparative study
III Congreso LatinoamericanoLasid
Lugar: Santiago de Chile; Año: 2013;
GUGLIELMONE HUGO A
Levels of transforming growth factor-β (TGF-β1) in concentrates of factor viii manufactured in UNC-Hemoderivados
Haemophilia World Federation Congress,
Año: 2010;
GUGLIELMONE HUGO A
Studies on the immunogenicity of factor VIII concentrate manufactured in UNC-Hemoderivados
Haemophilia World Federation Congress,
Año: 2010;
GUGLIELMONE HUGO A
No evidence for neonatigens formation in differents batchs of a double-virus inactivated factor VIII concentrate manufactured in Argentina?
XXII International Congress of the International Society on Thrombosis and Haemostasis
Año: 2009;
GUGLIELMONE HUGO A
Successful liver transplantation in a patient with mild haemophilia a and low-titre of factor viii inhibitor treated with recombinant factor viia: the first argentinian case studied?
XXII International Congress of the International Society on Thrombosis and Haemostasis
Año: 2009;
GUGLIELMONE HUGO A
Ileo-femoral thrombosis in a patient with elevated homocysteine due to three polymorphisms in the MTHFR gene?
XXII International Congress of the International Society on Thrombosis and Haemostasis
Año: 2009;
GUGLIELMONE HUGO A
Comparative ?in vitro? characterization of different prothrombin complex concentrate
XXI International Congress of the International Society on Thrombosis and Haemostasis
Año: 2007;
GUGLIELMONE HUGO A
Anticoagulation in a patient with severe preeclamptia, positive antibeta2-glycorpotein I and homozigosity for PAI-1 and MTHFR
XXI International Congress of the International Society on Thrombosis and Haemostasis
Año: 2007;
GUGLIELMONE HUGO A
PAI-1 gene 4G/5G genotype as an additional risk factor in patient with thrombosis: A retrospective cohort study.
XXI International Congress of the International Society on Thrombosis and Haemostasis
Año: 2007;
GUGLIELMONE HUGO A
Inhibición de la agregación plaquetaria por flavonoides aislados de Flavedria bidentis
XVIII Congreso Internacional de Hemostasia y Trombosis
Año: 2003;
GUGLIELMONE HUGO A
The anticoagulant effect of sulfhated flavonoids from Flaveria bidentis acting as heparin cofactor II agosnist?.
XVIII Congress the International Society on Thrombosis and Haemostasis
Año: 2001;
JLCABRERA, GUGLIELMONE HA AND ASGNESE AM
Inhibition of coagulation system by sulphated flavonoids from Flaveria Bidenti
Înternational Congress of Natural Products- IUPAC
Año: 2000;
GUGLIELMONE HUGO A
Prevalence and cofactor dependence in anticardiolipin antibodies isotypes in patients with autoimmune hepatitis
XVII International Congress on Thrombosis and Haemostasis
Año: 1999;
GUGLIELMONE HUGO A
Prevalence of lupus anticoagulant and anticardiolipin antibodies isotypes in a population with antiphospholipid syndrome
XVI International Congress on Thrombosis and Haemostasia
Año: 1997;
GUGLIELMONE HUGO A
-?2 Glycoprotein dependent and independent anticardiolipin antibodies in a population with viral infections"
XVI International Congress on Thrombosis and Haemostasia
Año: 1997;
GUGLIELMONE HUGO A
Un nuevo ensayo para determinar la actividad de proteina C en plasma humano: comparación con ensayos amidolílitico y coagulométrico"
XII Congreso Internacional de Hemostasia y Trombosi
Año: 1991;
GUGLIELMONE HUGO A
Formación de complejos "ïn vitro" entre el t-PA y la alfa-2 Glicoproteina asociada al embarazo 2-PAG)
XII Congreso Internacional de Hemostasia y Trombosis.
Año: 1991;